Regencell Bioscience Stock (RGC) up 60,000% YTD: 5 Things Behind Price Spike
Shares of a little-known Chinese herbal medicine company have surged this year, with a fresh rally seeing the price quadruple in less than a week.
It’s been a head-scratching move, since the company is unprofitable, and shares have moved on seemingly no news.
Regencell Bioscience Holdings, a Hong Kong-based firm specializing in traditional Chinese medicine, saw its US-listed stock soar 398% over the first two days of the week. But that move pales in comparison to the year-to-date increase, which amounted to roughly 60,000% through Tuesday’s close.
The company, which offers a proprietary oral formula it says can help treat disorders like ADHD and autism, has not generated any revenue, according to a regulatory…
